3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
98
Carcinoma, Non-Small-Cell Lung
32
Neoplasms
22
Neoplasm Metastasis
14
Carcinoma, Renal Cell
13
Prostatic Neoplasms
12
Lung Neoplasms
12
Small Cell Lung Carcinoma
10
Diabetes Mellitus, Insulin-Dependent, 12
10
Pancreatic Neoplasms
7
Uveal Melanoma
6
Skin Neoplasms
6
Ovarian Neoplasms
6
Brain Neoplasms
6
Advanced Cancer
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Mesothelioma
5
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Kidney Neoplasms
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma, Merkel Cell
4
Carcinoma, Hepatocellular
4
Carcinoma
4
Breast Neoplasms
4
Various Advanced Cancer
3
Interventions
Paclitaxel
4
pembrolizumab
2
pazopanib
2
efatutazone
2
Sorafenib
2
Radiotherapy, Intensity-Modulated
2
trametinib
1
tislelizumab
1
surufatinib
1
spartalizumab
1
sapanisertib
1
lenvatinib
1
fosbretabulin
1
dabrafenib
1
crolibulin
1
combretastatin
1
cabozantinib
1
atezolizumab
1
abemaciclib
1
Taxes
1
Imatinib Mesylate
1
Gefitinib
1
Doxorubicin
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
CUDC-907
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thyroid Carcinoma, Anaplastic
×
Ipilimumab
×
Clear all
No trials found.